Company & Sponsor Intelligence

University of Chicago

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting2

Completed7

Countries1

Therapeutic footprint

alzheimersanxietyautismbipolar_disorderdepressionepilepsyother_neurologyother_psychiatryparkinsons

Indexed studies

NCT05945628Basic Experimental Study of Hippocampal Memory Functions
other_neurology · United StatesNA

NCT00203957Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa
parkinsons · United StatesPHASE3

NCT05399498Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
depression · United StatesPHASE2

NCT03810703Differential Responses to Drugs and Sweet Tastes
bipolar_disorder · United StatesPHASE1

NCT02857244A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
parkinsons · United StatesPHASE2

NCT03371706Communication Bridge 2
alzheimers · United StatesNA

NCT04053036Effects of Drugs on Responses to Brain and Emotional Processes
autism · United StatesEARLY_PHASE1

NCT05356013Caplyta in Borderline Personality Disorder
other_psychiatry · United StatesPHASE2

NCT03238976Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy
anxiety · United StatesNA

NCT03964350Behavior Brain Responses
depression · United StatesEARLY_PHASE1

NCT06521437Hippocampal Network Function in Epilepsy
epilepsy · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →